Basma Adeem Medical Co. (9626.SR) — Income statement
Revenue, gross profit, operating income, net income, and EPS for Basma Adeem Medical Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 45↑34.0% | 34↑27.9% | 27↑21.0% | 22 | |
| Cost of Revenue | 32↑695.2% | 4↓78.1% | 18↑21.9% | 15 | |
| Gross Profit | 13↓55.4% | 30↑270.0% | 8↑18.9% | 7 | |
| Operating Expenses | |||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00 | 0.00↓100.0% | 3↑7.0% | 2 | |
| Other Expenses | 5↑29.6% | 4 | 0.00 | 0.00 | |
| Operating Expenses | 5↑29.6% | 4↑58.2% | 3↑7.0% | 2 | |
| Total Costs & Expenses | 37↑362.4% | 8↓61.5% | 21↑19.8% | 18 | |
| Operating Results | |||||
| Operating Income | 8↓68.7% | 26↑368.0% | 6↑25.4% | 4 | |
| Depreciation & Amortization | 0.00↓100.0% | 1↑7.3% | 1↑50.8% | 0.77 | |
| EBITDA | 8↓70.2% | 27↑295.0% | 7↑32.5% | 5 | |
| EBIT | 8↓68.7% | 26↑354.1% | 6↑29.3% | 4 | |
| Interest & Other Income | |||||
| Net Interest Income | 0.00↑100.0% | -0.64↓0.2% | -0.63↓32.4% | -0.48 | |
| Interest Income | 0.00↓100.0% | 0.10 | 0.00 | 0.00 | |
| Interest Expense | 0.00↓100.0% | 0.74↑16.5% | 0.63↑32.4% | 0.48 | |
| Non-Operating Income | 0.00 | 0.00↑100.0% | -0.17 | 0.00 | |
| Other Income / Expenses | -8↑68.7% | -26↓5378.2% | -0.47↑1.6% | -0.48 | |
| Income Before Tax | 0.00↓100.0% | 7↑34.2% | 5↑28.9% | 4 | |
| Income Tax Expense | 0.00↓100.0% | 0.48↑158.4% | 0.19↑33.3% | 0.14 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | 0.00↓100.0% | 6↑29.4% | 5↑28.7% | 4 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 7↑15.9% | 6↑29.4% | 5↑28.7% | 4 | |
| Bottom-Line Net Income | 7↑15.9% | 6↑29.4% | 5↑28.7% | 4 | |
| EPS (Basic) | 0.40↑25.0% | 0.32↑33.3% | 0.24↑26.3% | 0.19 | |
| EPS (Diluted) | 0.40↑25.0% | 0.32↑33.3% | 0.24↑26.3% | 0.19 | |
| Weighted Average Shares | 18↓9.8% | 20↑0.0% | 20↑0.0% | 20 | |
| Weighted Average Diluted Shares | 18↓9.8% | 20↑0.0% | 20↑0.0% | 20 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.